Rhythm Pharmaceuticals, Inc. Common Stock
|Range Today||$26.73 - $27.62|
|52 Week Range||$21.38 - $33.81|
Rhythm Pharmaceuticals, Inc. develops and commercializes peptide therapeutics for the treatment of gastrointestinal (GI) diseases and genetic deficiencies. It focuses on the treatment for Prader-Willi Syndrome (PWS) and Pro-Opiomelanocortin (POMC) deficiency obesity. The company was founded by Bart Henderson in February 2010 and is headquartered in Boston, MA.